We are live on ! Find out more
CRT

Cross Timbers Royalty Trust

19 hedge funds and large institutions have $1.66M invested in Cross Timbers Royalty Trust in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.33% less ownership

Funds ownership: 2.97%2.63% (-0.33%)

10% less funds holding

Funds holding: 2119 (-2)

13% less capital invested

Capital invested by funds: $1.92M → $1.66M (-$257K)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
6
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CRT Hedge Fund Activity: Q3 2024 in Review

19 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Cross Timbers Royalty Trust (CRT) for Q3 2024, worth a combined $1.66M — down 13% from $1.92M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CRT and 0 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 3 added.

The largest buyer was UBS Group, adding an estimated $107K. The largest seller was Morgan Stanley, cutting an estimated $208K.

  • 19 institutional investors held Cross Timbers Royalty Trust (CRT) as of Q3 2024, down from 21 in Q2 2024.
  • Funds reported $1.66M of Cross Timbers Royalty Trust stock for Q3 2024, down 13% quarter-over-quarter.
  • 0 funds opened new Cross Timbers Royalty Trust positions in Q3 2024 and 2 closed out, a net change of -2 holders.
  • The largest Cross Timbers Royalty Trust buyer in Q3 2024 was UBS Group, an estimated $107K added.
  • The largest Cross Timbers Royalty Trust seller in Q3 2024 was Morgan Stanley, an estimated $208K sold.

Based on aggregated 13F filings for Q3 2024.